Navigation Links
Award Winning Vascular Imaging Device Company Announces New Patents
Date:4/13/2011

COLD SPRING HARBOR, N.Y., April 13, 2011 /PRNewswire/ -- AccuVein LLC announced today that the United States Patent and Trademark Office has granted the company a patent for its vascular illumination technology and that a second patent has been allowed.

"With more than a dozen additional patents pending in the United States and around the world we're very pleased with this news," said Ron Goldman, President and CEO of AccuVein. "Our technology team has built a stellar portfolio of intellectual property that enables us to deliver the only hand-held vein illumination system in the market."

Called "miles ahead" by Frost & Sullivan, the AccuVein AV300 is now in use in over 575 hospitals in the United States alone. This makes it the most widely deployed vein illumination system in the world. It helps healthcare professionals locate veins for blood draw, IV infusion and blood donation by projecting a pattern of light on patient's skin that reveals the position of underlying veins.  This 10-ounce, hand-held device is available with a range of hands-free options so that it can quickly free the practitioner's hands to perform the venipuncture.

"We're extremely gratified that the USPTO has recognized the significant intellectual property position that we have developed for vein illumination." said Joe Zott, Vice President of Operations and Engineering for AccuVein.  "We continue to build value for our customers through innovation. Industry recognition such as our gold-level Medical Design Excellence Award and Frost & Sullivan's Product of the Year award attest to this."

About AccuVein LLC

AccuVein LLC is a supplier of innovative, cutting-edge medical devices. The AV300 is a breakthrough product, allowing health care providers to see a map of the position of peripheral veins on the skin's surface with the goal of helping to improve venipuncture procedures. Built using AccuVein's expertise in medical device miniaturization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. AccuVein has filed applications for more than a dozen patents on the AV300's technology. It is in use at more than 575 U.S. hospitals and available for sale in 60 countries. For more information please visit www.accuvein.com

For sales inquiries: Joe McCormick, 888-909-8888, joe.mccormick@accuvein.com.


'/>"/>
SOURCE AccuVein LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
2. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
3. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
4. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
7. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
8. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
9. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
10. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
11. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... BUDAPEST , Ungarn, February 12, 2016 ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ... gab heute positive Ergebnisse seines klinischen Forschungsprogramms ... und Asthma-Patienten beschäftigt, ergab Verbesserungen ihrer respiratorischen ... Indiso ltd , ein Medizintechnikunternehmen, das ...
(Date:2/11/2016)... , Feb. 11, 2016 Stem cells are ... characterized by self-renewal and the capacity to differentiate into ... new discovery, as the first mouse embryonic stem cells ... not until 1995 that the first culturing of embryonic ... cells were not produced until 2006 As a result ...
(Date:2/11/2016)... , Feb. 11, 2016  Walgreens has committed to ... states and Washington, D.C. as part ... that was commended by shareholder advocacy organization As You Sow. ... You Sow. "Many people hold on to unneeded drugs because ... have tragic consequences." --> Conrad MacKerron , ...
Breaking Medicine Technology:
(Date:2/11/2016)... Angeles, CA (PRWEB) , ... February 11, 2016 , ... ... Loss System, a product marketed as a weight loss dietary supplement, is being recalled ... medical group Beverly Hills Physicians, because there is not a single supplement on the ...
(Date:2/11/2016)... ... ... Registered nurses, licensed practical nurses and nursing aides who treat stroke patients ... to Heal” on Thursday, February 25 from 9:00 to 11:00 a.m. at the ... of ANSA Consultants, who will discuss clinical best practices throughout the continuum of stroke ...
(Date:2/11/2016)... ... ... The Journal of Pain Research has seen a significant increase in ... from the Scopus database (Elsevier B.V.) and is a measure of a journal's impact. ... a three year period and also the importance of the journals where the citations ...
(Date:2/11/2016)... IL (PRWEB) , ... February 11, 2016 , ... ... to the healthcare industry, ranked among the top five firms in the “2015/2016 ... and HIT Implementation Support and Staffing. KLAS is a research and insights firm ...
(Date:2/11/2016)... ... February 11, 2016 , ... Thermi™, a world leader in ... announce the promotions of Allison Kelly to executive vice president of the company’s ... president of North American capital sales, and Wendy Oseas to vice president of ...
Breaking Medicine News(10 mins):